Spinach

R&D and Drug Discovery Services

R&D and Drug Discovery Services

R&D and Drug Discovery Services

Synthesis and semi synthesis of a novel compound is the first major step in discovery services, our main focus is on medicinal chemistry R&D and drug discovery. The research division covers small molecule inhibitor research, peptide synthesis (solid phase), chiral compounds, antibiotic & non-antibiotic segments.

The focus is on,

  • Drug Discovery Research: Identification of hit to lead for various CNS, oncology targets. Usage of computational modeling, virtual screening and other efficient methods to assist discovery research.
  • New Reactions: Development of new reactions and methodologies for the efficient synthesis of bioactive molecules from lab to kilo scale.
  • Services for PET and SPECT imaging: We are keen in providing medicinal chemistry services to academic, industrial and research institutions for developing PET imaging compounds (reference and precursor compounds).
  • Cancer research: On-demand synthesis of molecules to support cancer research in pre-clinical and clinical settings for academia and industry.
  • Inhibitor Discovery Services (not limited to): CNS discovery, neurodegeneration and neuroinflammation, Kinase inhibitors, Ion Channel discovery, Epigenetics, Heat Shock Proteins, Cannabinoid receptors (and related enzymes), COX, MMP, HIV protease, PI3K, PARP, Raf, SGLT, mTOR, JAK, JNJ, HER2, GABA, GluR, GSK, caspase.
  • Assay Development
  • Research on Contrast agents, Optical and Fluorescence imaging agents, NIR imaging agents and dyes.

Copyright ©2016 Spinach Pharma Pvt.Ltd. All rights reserved